-
公开(公告)号:BRPI0813658A2
公开(公告)日:2016-10-18
申请号:BRPI0813658
申请日:2008-06-23
Applicant: SOLVAY PHARM BV
Inventor: STOIT AXEL , KRUSE CORNELIS G , TURSKI LECHOSLAW A , TULP MARTINUS TH M , VADER SANDER
IPC: A61K31/135 , A61P25/24 , C07C291/04
-
公开(公告)号:BRPI0813657A2
公开(公告)日:2016-10-18
申请号:BRPI0813657
申请日:2008-06-23
Applicant: SOLVAY PHARM BV
Inventor: STOIT AXEL , KRUSE CORNELIS G , TURSKI LECHOSLAW A , TULP MARTINUS TH M , VADER SANDER
IPC: C07D487/04 , A61K31/519 , A61P11/00 , A61P15/10
-
公开(公告)号:ZA200908868B
公开(公告)日:2010-09-29
申请号:ZA200908868
申请日:2009-12-11
Applicant: SOLVAY PHARM BV
Inventor: TURSKI LECHOSLAW A , STOIT AXEL , KRUSE CORNELIS G , VADER SANDER , TULP MARTINUS TH M
IPC: A61K20060101 , A61P20060101 , C07D20060101
-
公开(公告)号:PL2023909T3
公开(公告)日:2010-04-30
申请号:PL07728391
申请日:2007-04-23
Applicant: SOLVAY PHARM BV
Inventor: DE BRUIN NATASJA M W J , VAN DRIMMELEN MARLIES L , HERREMANS ARNOLDUS H J , TULP MARTINUS TH M , KRUSE CORNELIS G
IPC: A61K31/00 , A61K31/439 , A61K31/4439 , A61K31/551 , A61P25/18
-
公开(公告)号:ES2336275T3
公开(公告)日:2010-04-09
申请号:ES07728391
申请日:2007-04-23
Applicant: SOLVAY PHARM BV
Inventor: DE BRUIN NATASJA M W J , VAN DRIMMELEN MARLIES L , HERREMANS ARNOLDUS H J , TULP MARTINUS TH M , KRUSE CORNELIS G
IPC: A61K31/00 , A61K31/439 , A61K31/4439 , A61K31/551 , A61P25/18
Abstract: Uso de un agonista muscarínico-1 (M1) para la preparación de una composición farmacéutica para el tratamiento, mejora o prevención de trastornos de control de impulsos.
-
公开(公告)号:CA2699961A1
公开(公告)日:2008-12-31
申请号:CA2699961
申请日:2008-06-23
Applicant: SOLVAY PHARM BV
Inventor: TURSKI LECHOSLAW A , STOIT AXEL , KRUSE CORNELIS G , VADER SANDER , TULP MARTINUS TH M
IPC: C07C291/04 , A61K31/135 , A61P25/24
Abstract: The invention concerns venlafaxine-N-oxide and O-desmethylvenlafaxine-N-oxide as prodrugs of venlafaxine and its major (active) metabolite O-desmethylvenlafaxine respectively, to pharmaceutical compositions containing these N-oxides, to methods for preparing them, and methods for preparing compositions. The invention relates to N-oxide, having formula (1), wherein R1 is H or CH3, and tautomers, stereoisomers, hydrates and solvates thereof. The invention also relates to the uses of the N-oxides and compositions, particularly for the manufacture of medicaments useful in the treatment of affections or diseases effectively treatable - albeit with side effects - with venlafaxine.
-
公开(公告)号:BRPI0518465A2
公开(公告)日:2008-11-18
申请号:BRPI0518465
申请日:2005-12-06
Applicant: SOLVAY PHARM BV
Inventor: VAN HES ROELOF , SMID PIETER , KRUSE CORNELIS G , TULP MARTINUS TH M
IPC: C07D401/14 , A61K31/519 , A61P25/00 , C07D471/04 , C07D487/04 , C07D513/04
Abstract: The present invention relates to a group of novel tetrahydropyridin-4-yl indoles with a dual mode of action: serotonin reuptake inhibition and affinity for dopamine -D 2 receptors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said tetrahydropyridin-4-yl indoles. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The invention relates to novel tetrahydropyridin -4-yl indoles of the formula (I) and tautomers, stereoisomers, prodrugs, N -oxides, pharmacologically acceptable salts, hydrates and solvates thereof , wherein: - R 1 is hydrogen, halogen, alkyl (C 1-3 ) or alkoxy(C 1-3 ), CN or CF 3 , - R 2 is hydrogen or alkyl (C 1-3 ), R 3 is hydrogen or alkyl (C 1-3 ), - Z is hydrogen or alkyl (C 1-3 ), alkoxy(C 1-3 ) or alkylthio(C 1-3 ), - A is hydrogen or alkyl (C 1-3 ), or - A and Z together form a saturated or (partly) unsaturated 5 - or 6- membered ring which may be substituted with halogen, alkyl (C 1-3 ) or phenyl, in which ring Z represents carbon, sulfur of nitrogen .
-
公开(公告)号:ZA200704156B
公开(公告)日:2008-05-28
申请号:ZA200704156
申请日:2007-05-22
Applicant: SOLVAY PHARM BV
Inventor: ROELOF VAN HES , KRUSE CORNELIS G , PIETER SMID , TULP MARTINUS TH M
IPC: A61K20090101 , A61P20090101 , C07D20090101
Abstract: The present invention relates to a group of novel 3 -(2-piperidin-4-yl-ethyl)-1H-indole derivatives with a dual mode of action: serotonin reuptake inhibition and affinity for dopamine-D 2 receptors and to methods for the preparation of these compounds. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1) wherein the symbols have the meanings given in the specification.
-
公开(公告)号:CA2654719A1
公开(公告)日:2007-12-21
申请号:CA2654719
申请日:2007-06-15
Applicant: SOLVAY PHARM BV
Inventor: TULP MARTINUS TH M , VAN SCHARRENBURG GUSTAAF J M , MCCREARY ANDREW C
IPC: A61K31/496 , A61K31/198
Abstract: The invention concerns the use of a combination preparation of SLV308 or its N-oxide, or pharmacologically acceptable salts of those compounds (I), ( II) and L-DOPA, for simultaneous, separate or sequential use in the treatmen t of disorders requiring recovery of dopaminergic function, in particular Pa rkinson's disease and restless leg syndrome.
-
公开(公告)号:CA2649917A1
公开(公告)日:2007-11-15
申请号:CA2649917
申请日:2007-04-23
Applicant: SOLVAY PHARM BV
Inventor: DE BRUIN NATASJA M W J , VAN DRIMMELEN MARLIES L , HERREMANS ARNOLDUS H J , KRUSE CORNELIS G , TULP MARTINUS TH M
IPC: A61K31/00 , A61K31/439 , A61K31/4439 , A61K31/551 , A61P25/18
Abstract: The invention relates to a novel use of compounds and pharmaceutically acceptable salts thereof, which are muscarinic, in particular muscarine-1 (M 1 ) agonists. These compounds are useful for the preparation of medicaments for treatment, amelioration or prevention of impulse control disorders. These include impulse control disorders 'Not Elsewhere Classified' such as intermittent explosive disorder, pyromania, kleptomania, pathological gambling and trichotillomania; and impulse control disorders 'Not Otherwise Specified' such as: compulsive buying disorder, binge eating and binge drinking disorder, impulsive self-injurious behaviour such as pathological skin picking, nail-biting and nose-picking, gouging, head banging and self- biting; paraphilic sexual addictions, including exhibitionism, fetishism, frotteurism, pedophilia, masochism, sadism, transvestic fetishism and voyeurism; compulsive Internet use and excessive mobile phone use.
-
-
-
-
-
-
-
-
-